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Abstract The galectin-1 gene encodes a ~-galactoside-binding 
protein whose overexpression is associated with neoplastic trans- 
formation and loss of differentiation. Transient transfection as- 
says of a series of deletions constructs (pGAT) showed that the 
galectin-I promoter is highly active in cells both expressing and 
non-expressing the endogenous gene, and that the basal activity 
is determined by sequences encompassing the transcription start 
site ( -50/+ 50). Both an upstream ( -50 / -26)  and a downstream 
position-dependent (+ 10/+ 50) cis-elements are necessary for ef- 
ficient transcriptional activity and are able to bind nuclear pro- 
teins. 
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by transient ransfection experiments of promoter constructs 
and by band-shifting experiments. We found that a small DNA 
region of no more than 100 bp surrounding the transcription 
start site ( -50/+ 50) accounts for most of the transcriptional 
activity. This regulatory region includes two elements that are 
both required for efficient transcription in cultured cells and 
that can bind proteins present in nuclear extracts. One element 
is located just upstream from a putative TATA box; the other 
one is located between 10 and 50 bp downstream from the 
transcription initiation site and its function is position-depend- 
ent. Finally, we show that all the promoter constructs contain- 
ing at least these two elements and up to 2300 bp upstream from 
the transcription start point, are highly active when transfected 
in cultured cells either expressing or not the endogenous gene. 
1. Introduction 
Galectin-1 is a member of galectins, a family of structurally 
related proteins that share the ability to bind fl-galactosides 
through a conserved carbohydrate recognition domain [1-3]. 
Galectin-1 has been implicated in such biological processes as 
cell-cell [4] and cell-matrix interaction [5], cell differentiation 
and growth regulation [6,7], maturation of T-lymphoblastoid 
cells [8] and in tumor progression [9]. Galectin-1 is a develop- 
mentally regulated gene [10] whose activity is strongly modu- 
lated during cell differentiation and transformation. Acquisi- 
tion of tumorigenic phenotype and loss of differentiated func- 
tions are often accompanied by strong stimulation of galectin-1 
expression in several cell systems and in human tumors [11-14]. 
Galectin-1 expression in rat thyroid and liver cell lines is very 
low or undetectable but increases 100-fold upon transforma- 
tion of these cells by cellular or viral oncogenes [15]. By con- 
trast, treatment with a differentiating agent of some trans- 
formed cells leads to extinction of galectin- 1expression [16,17]. 
Nuclear run-on experiments showed that such regulation of this 
gene occurs, at least in part, at the transcriptional level [15]. 
Finally, somatic cell hybrids obtained by fusing human os- 
teosarcoma expressing cells with rat liver differentiated non- 
expressing cells, show a loss of both differentiated functions 
and tumorigenic phenotype, and activation of the previously 
silent rat galectin-1 alleles [18]. 
We have previously characterized the structure of the mouse 
galectin-I gene and identified the transcription start site [19]. 
Because of the apparent significance of the galectin-1 gene 
during development and transformation, we have initiated 
studies to define functional elements of the galectin-I promoter 
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2. Materials and methods 
2.1. Plasmid construction 
The galectin-1 promoter fragments were excised from the previously 
described pHS2 plasmid [19] by appropriate restriction endonucleases. 
An HindIII/XmnI fragment, spanning the genomic region -2300/+ 50 
relative to the transcription start site, was cloned in the pUCl9 vector. 
The 5' deletions were obtained by cleavage at unique sites with EcoRI, 
StuI, Pstl, NarI, and SrnaI restriction endonucleases, respectively. 
Smaller promoter fragments contained in pGAT50, 26 and 16, respec- 
tively, were obtained by PCR amplification using appropriate oligonu- 
cleotides containing an artificial Smal restriction site at the 5'-end. For 
the D series, a 40 bp AvaI Xmnl fragment of the first exon (+ 10 + 50) 
was deleted. The same deleted fragment was cloned in tandem and in 
both directions in the pGAT50D vector to obtain the F40 plasmid 
series. The fragments were excised from the vector using appropriate 
restriction enzymes, flush-ended at the 5' end by Klenow polymerase 
when required, and then cloned in the SmaI site upstream from the 
CAT reporter gene in the pEMBL8CAT expression vector. All con- 
structs were checked by sequencing with the chain-termination method 
[20]. Chimeric pGAT plasmids were purified with the Plasmid Maxi Kit 
(Qiagen). 
2.2. Cell culture, transient ransfections and CAT assays 
NIH3T3 mouse fibroblast, PC C13, PC myclrafrat hyroid cells [15] 
and FAO rat liver cells [21], were cultured in DMEM supplemented 
with 10% foetal calf serum (IGNI Flow), plated at a density of about 
250,000 cells per 60 mm Petri dish 16 h before transfection. DNA 
transfections were carried out by the calcium phosphate precipitation 
method [22]. Cultures were co-transfected with 10/lg of test plasmid 
and 2/lg of a vector carrying the luciferase or fl-galactosidase g nes 
under the control of the CMV and SV40 promoter element, respectively 
(pCMV-LUC, pSVfl-gal) as internal standard for transfection effi- 
ciency. 2.5 h after transfection, PC C13 and PC myelrafwere xposed 
to 15% glycerol in HEPES-buffered saline solution for 1 min and then 
re-fed with growth medium. Cell extracts were prepared 48 h after 
tranfection by several cycles of freezing and thawing. CAT assays were 
performed as described [22]. Protein concentration was determined by 
the Bio-Rad assay. The CAT activity in the extract of the transfected 
cells was quantified by counting the amount of [~4C]chloramphenicol 
converted to the mono-acetylated forms, normalized to the luciferase 
or to ]3-galactosidase activity. Luciferase activity in cell extracts was 
0014-5793/95l$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSD1 0014-5793(95)01032-7 
160 P Salvatore t al./FEBS Letters 373 (1995) 159 163 
measured essentially according to de Wet et al. [23]. Cells were rinsed 
once with phosphate buffer and then lysed in 0.2 M Tris (pH 
7.6) + 0.1% Triton X-100 (0.2 ml for 60 mm dishes). Lysed cells were 
scraped and spun for 2 min. Supernatants were recovered for luciferase 
and protein assays. Luciferase activity was determined using the lumi- 
nometer Monolight 2010 (Analytical Luminescence Lab). 20/11 of ly- 
sates were automatically mixed with 100/zl of the luciferase substrate 
solution (20 mM Tris, pH 8, 4 mM MgSO 4, 0.1 M EDTA, 30 mM DTT, 
0.5 mM ATP, 0.5 mM o-luciferin, and 0.25 mM coenzyme A) and 
emitted fluorescence was measured for 15 s. 40/zg of total protein 
extract were assayed forfl-galactosidase activity as previously described 
[22]. Equal amounts offl-galactosidase activity (routinely 1 pM corre- 
sponding to about 100/zg of total protein extract) were used for the 
determination of CAT activity. Each transfection experiment was re- 
peated at least three times and gave reproducible r sults. 
2.3. Nuclear extracts and gel-retardation assays 
Nuclear protein extracts were prepared as described [24]. Frag- 
ment A (-60/+ 5), fragment B (-50/+ 5) and fragment C (+ 10/+ 50) 
were used as probes for binding reactions. Labelling reaction was 
performed using Klenow polymerase (Amersham) and [0~-32P]dATP or 
[e-32p]dGTP or T7 polynucleotidekinase (Boehringer-Mannheim) and 
[y-32p]dATP. Synthetic double-stranded oligonucleotides u ed as com- 
petitors were purchased from Promega. Gel-shift assays were per- 
formed as described [25], in the presence of 3/~g poly(dI/dC) per sample 
as non- specific competitor. Samples were loaded on 5% non-denatur- 
ing polyacrylamide gels. The gels were then dried and subjected to 
autoradiography. For gel retardation competition assays, various 
amounts of cold competitor DNA were added during preincubation. 
3. Results 
3.1. Deletion analysis of galectin-1 promoter egion 
To localize cis-elements that regulate the efficiency of the 
galectin-1 gene promoter, a series of 5'-deleted promoter frag- 
ments, maintaining 50 bp 3' from the initiation site, were fused 
to CAT gene in the pEMBL8CAT vector and used for transient 
transfections into the NIH3T3 mouse fibroblast cell line. This 
cell line expresses high levels of endogenous galectin-1 mRNA 
(data not shown). Plasmids pEMBL8CAT and pRSV-CAT 
(containing the Rous sarcoma virus long terminal repeat) were 
used as negative and positive control, respectively. The fusion 
constructs with their relative CAT activity are shown in Fig. 1. 
Construct pGAT-2300, containing 2300 bp upstream from the 
initiation start site, is able to direct the transcription of the 
reporter gene with an efficiency comparable to that of the 
pRSV-CAT positive control. Sequences up to 60 bp upstream 
from the transcription start site could be removed without any 
significant loss of CAT activity. Removal of sequences contain- 
ing two overlapping Spl binding sites reduced the promoter 
activity to 65% (plasmid pGAT-50). Deletion of further se- 
quences to -26  almost completely abolished CAT activity 
(plasmid pGAT-26). The 5' deletion analysis suggests that ga- 
Table 1 
Galectin-1 promoter activity in different cell lines 
Plasmid Relative CAT activity* 
NIH3T3 FAO PC C13 PC myc/raf 
pGAT2300 100 + 9.2 90 + 7.5 110 + 8.8 100 + 6 
pGAT60 95 + 2 100 + 7.8 90 + 9.2 110 + 8.2 
pGAT50 65 + 7.5 60 + 5.1 70 + 4.3 75 + 5 
pGAT26 10 + 3.3 5 + 1 5 + 1.1 15 + 3.2 
*Expressed as a percentage of activity obtained by transfection of 
pRSVCAT in NIH3T3 which was arbitrarily assigned 100% and nor- 
malized for luciferase activity of the extract. 
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~1 CAT I pGAT400 1N ± 4.6 
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pOAT2S 10 ± 3-:1 
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Fig. 1. Deletion analysis of the galectin-1 gene promoter region. (Top) 
Schematic diagram of the mouse galectin-1 gene 5'-flanking region. The 
first exon (dashed box), the start site of transcription (+ 1) and some 
restriction sites are indicated. (Bottom) 5'-deleted clones contain 50 bp 
of the first exon. All the constructs shown were transiently transfected 
in NIH3T3 cells. Relative CAT activity was normalized to that of the 
pRSVCAT, which was arbitrarily assigned 100% activity. All extracts 
were adjusted to identical luciferase or fl-galactosidase activity. The 
results shown represent the averages of at least five independent trans- 
fection experiments with two plasmid preparations. Standard devia- 
tions of the means are indicated. 
lectin-1 promoter sequences from -50  to + 50 are sufficient o 
drive efficient expression of a reporter gene, and that nucleo- 
tides between - 50 and - 26 are essential for promoter activity. 
The presence of the Spl consensus sequences ( -60 / -50)  
slightly increases the transcription efficiency but is not a major 
determinant of the basal activity. 
3.2. Analysis of the downstream region 
To determine whether there are regulatory sequences down- 
stream the start site, further constructs maintaining only 9 bp 
3' from the transcription start were prepared. With these dele- 
tion mutants, pGAT2300A (-2300/+9), pGAT60A ( -60/+9)  
and pGAT50A ( -50/+ 9), the CAT activity was almost com- 
pletely abolished (Fig. 2). This result indicates that downstream 
sequences, located between + 10 and +50, are essential for 
promoter activity. Comparing the results obtained with plas- 
mids pGAT50A and pGAT26, it is clear that the downstream 
+ 10/+ 50 and the upstream - 50/- 26 elements are interdepend- 
ent and both necessary for efficient transcription. We next 
generated further constructs in which the downstream sequence 
+ 10/+ 50 was inserted, in both directions and in tandem, up- 
stream from the -50 /+ 9 region (plasmids pGAT-F40, pGAT- 
F40inv and pGAT-2F40inv). Transfection of these plasmids 
revealed that the CAT activity was not restored (Fig. 2). These 
results suggest hat the function of the downstream element is 
position-dependent. 
3.3. Nuclear proteins bind both upstream and downstream 
elements 
To investigate if nuclear factors bind sequences located 
around the transcription start site, we performed mobility shift 
experiments using as probes the three DNA fragments A, B and 
C (Fig. 3). Fragment A corresponds to the - 60/+ 5 region and 
includes two overlapping Spl consensus equences; the results 
(Fig. 4A) showed that a complex is formed with NIH3T3 nu- 
clear extract that is specifically inhibited by the addition of a 
50-fold molar excess of both cold fragment A and a cold dou- 
P Salvatore t al./FEBS Letters 373 (1995) 159-163 161 
Relative CAT 
+1 +1o activity 
'b~,~ CAT I pGAT2300 100 + 9.2 
p AT2300A n ± 2.2 
pGATeO tS :t 2 
pGATS0A 14 + 1.S 
pGAT50 6S + 7.5 
,~A 'T - ]  pGATSOA 10 + 2.2 
pGAT F40 10 + 3 
pGAT F4Oinv 7 ± 4 
~ ~ ' - ]  pGAT2F4Oinv 12 + 4 
Fig. 2. Effects of deletion or translocation of the + 10/+ 50 region on 
the activity of pGAT constructs. The AvaI/XmnI (+ 10/+ 50) fragment 
was deleted from the pGAT-2300, pGAT-50 and pGAT26 plasmids 
(pGAT/I), or translocated upstream from the start site in both orienta- 
tions and in tandem (pF40 series). The + 1/+ 10 region (hatched box) 
and the + 10/+ 50 (open box with arrow indicating the 5'-3' orientation) 
are indicated, as are the deleted sequences. The CAT activities shown 
on the right are expressed relative to that of pRSVCAT, which was 
arbitrarily assigned 100%. The results represent the averages ofat least 
five independent transfection experiments. Standard eviations of the 
means are indicated. 
ble:stranded oligonucleotide containing a consensus sequence 
for the binding of Spl factor. This experiment indicated that 
Spl transcription factor binds this fragment. 
To investigate if less abundant factors are able to bind these 
sequences we used fragment B as a probe. Fragment B (-50/ 
+ 5) consists of the same region except for the Spl consensus 
sequences that have been deleted; the results of this experiment 
(Fig. 4B) indicated that complexes are formed and specifically 
inhibited by the addition of a 50-fold molar excess of cold 
fragment B but not by an oligonucleotide containing Spl con- 
sensus equences. This suggests that nuclear factors other than 
Spl bind specifically to sequence - 50/+ 5. 
The last probe used in these experiments was the AvaI/XmnI 
fragment C that corresponds to the downstream element de- 
scribed above (+ 10/+ 50). Also in this case retarded bands were 
specifically competed by a 50-fold molar excess of the cold 
fragment C but formation of the complexes was not inhibited 
by an unrelated competitor double stranded oligonucleotide 
(Fig. 4C). We next verified whether known transcription factors 
were involved in the complex with fragment B or fragment C. 
We performed competition assays with a 100-fold molar excess 
of several cold commercially available double-stranded ol-
igonucleotides (Promega Corp., Madison, WI). These included 
oligonucleotides containing DNA binding sites for the follow- 
ing transcription factors: AP1, AP2, OCT1, CTF/NFI, GRE, 
AP3, CREB and NFkB. In no case was the retardation ofboth 
fragment B or fragment C eliminated ( ata not shown). These 
results indicate that both downstream and upstream elements, 
which have been shown to be necessary and sufficient to drive 
efficient expression, are bound by yet unidentified nuclear pro- 
teins. 
3.4. Tranfections of gal/CA T constructs in galectin-1 expressing 
and non-expressing cell lines 
To identify possible cis-elements of the galectin-1 gene regu- 
latory region involved in the differential expression of the en- 
dogenous gene in different cell lines, we performed transfection 
experiments of some representative pGAT constructs (pGAT- 
2300, -60, -50 and -26) in PC C13, PC myclrafand FAO cell 
lines. PC C1 3 is a rat thyroid differentiated cell line in which 
the galectin-1 mRNA levels are very low, while PC myclrafis 
the transformed high tumorigenic counterpart that shows a 
100-fold increase of galectin-1 expression [15]; FAO are rat liver 
differentiated cells in which the galectin-1 mRNA is not detect- 
able by Northern blot assay [18]. The results of the CAT assays 
are summarized inTable 1. In all cell lines the CAT activity was 
comparable for each transfected plasmid with that observed in 
NIH3T3 extracts. This result indicates that sequences responsi- 
ble for the differential expression of the endogenous gene are 
not present or not functional in the genomic region - 2300/+ 50 
of the galectin-1 gene. 
4. Discussion 
Galectin-1 gene expression isdevelopmentally regulated and 
may vary dramatically during tranformation events both in cell 
lines and in mammalian tissues. For this reason in the present 
work we have focused our attention on the identification of the 
DNA sequences necessary for the basal transcription of the 
galectin-1 gene and of possible cis-elements involved in the 
differential expression of the gene. To our knowledge this is the 
first characterization f the regulatory region of a gene coding 
for a galectin. 
4.1. Identification of minimal promoter elements 
Using transient CAT assay we have demonstrated that the 
galectin-1 minimal promoter is composed of sequences from 
-50 to +50 relative to the transcriptional start site; the 
presence of two overlapping Sp 1 binding sites located between 
-50 and -60 moderately increases the transcriptional effi- 
ciency. This means that transcriptional ctivators other than 
Spl are responsible for basal promoter activity. Moreover, the 
expression of CAT gene was for each pGAT plasmid compara- 
ble in strength to that produced by SV2CAT and RSVCAT in 
which strong viral promoters drive the CAT gene. We also 
show that the galectin-1 minimal promoter is regulated by the 
interaction of at least wo elements: the first is located between 
- 50 and - 26, just upstream from a sequence that resembles a 
-Be -79 -60 -Se -40 -3e -Z0 -10 +1 
~catg~aattggctg~tccccgggaggggqmgactc~cg~gtctgatccagt~©m~gtcgg~gcct~gcccGTCTCTC 
C.AAT Box SP'J. S i tes  TATA BOX 
I fragment A I 
L fragment B [ 
+10 -~.e +3~ -*~ ÷50 -H~ ÷Te +79 
G G~G GAGTCTT L'TGACT GCT GG'T GGAGCAGG'r CT CAGC, AAT C'T CTT C GCrTC.AGCi'T C.AATCAT ~ C~ 
L - -  fregmem C' J NetAZaCys 
Fig. 3. Nucleotide sequence of the mouse galectin-I gene region sur- 
rounding the transcription start site. Putative regulatory elements 
(CAAT and TATA box and Spl binding sites) are in bold. The arrow 
indicates the transcription start site (+ 1). Capital etters indicate the 
transcribed sequences. The first three amino acid of the first exon are 
indicated. The fragments used for the band-shifting experiments are 
shown (fragments A, B and C). 
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A 
Probe  
Compet i tor  . . . . .  
NIH3T3 extract  
F ragment  A 
Ft. A Spl Unr. 
s~g 8~g ~ug 8~g 
B 
Probe  
Compet i to r  
NIH3T3 ext ract  
F ragment  B 
Fr.B Spl 
15~g 15pg 15pg 
C 
Probe  F ragment  C 
Compet i to r  . . . . .  Fr.C Unr. 
N IH3T3 ext ract  ~ 15~g 15~g 15~g 
rig. 4. Gel electrophoresis mobility shift analysis of the galectin-1 gene -60/+ 50 region. (A) Fragment A (-60/+ 5) was used as a probe. The specific 
omplex was eliminated by competition with a 50-fold molar excess of cold fragment A or of cold double-stranded oligonucleotide containing an 
pl consensus sequence (ATTCGATCGGGGCGGGGCGAG). No competition was observed in the presence of a 200-fold molar excess of an 
nrelated DNA fragment (TCGGAAGTCGTAGCCTGAGGTTCGTAGCTT CG). (B) Fragment B (-50/+ 5) was end-labelled and the specific 
omplex was competed by a 50-fold molar excess of unlabelled fragment but not by a 200-fold molar excess of the oligonucleotide containing an 
pl binding site. (C) The + 10/+ 50 fragment C was used as a probe. The complex was inhibited by a 50-fold molar excess of fragment C and not 
,y a 200-fold molar excess of the unrelated DNA fragment. Arrows indicate the unbound probes. Exposure time for panel A was 12 h and for panel 
l and C was 72 h. 
"ATA box; the second is located downstream from the tran- 
cription start (+ 10/+ 50). When either element is removed, the 
ranscription efficiency drops dramatically. A similar structure 
~as been found for the glial fibrillary acidic protein promoter 
26]. 
The analysis of the upstream element does not reveal any 
anonical sequence for the binding of known transcription fac- 
ors; the presence o f -50 / -26  sequences could be necessary for 
he binding of regulatory factors to the putative adjacent 
"ATA box. This could explain why no efficient ranscription 
driven by the pGAT-26 plasmid that contains the putative 
"ATA box but no other nucleotide at its 5'-end. Alternatively, 
he TATA sequence could be non-functional nd other cis- 
lements could exert its function. Interestingly, the region sur- 
ounding the transcriptional start site ( -  3/+ 7) of both the mur- 
ae (CCCGTCTCTC) and the human galectin-1 gene [27] 
CCCATCTCTC), matches the consensus equence for initia- 
3r elements (Inr) ( -3  YYCAYYYYYY + 7) [28] and shows 
homologies with the Inr regions of other genes [29]. Inr ele- 
ments have been described both in the context of TATA box- 
containing and in TATA-Iess promoters [30] and appear to be 
essential for accurate transcription i itiation. The Inr elements 
can function cooperatively with other transcriptional elements 
including TATA boxes or their counterparts, and with down- 
stream regulatory regions, as in the case of the terminal de- 
oxynucleotidyltransferase (TdT) promoter [30]. 
The downstream region (+ 10/+ 50) is also required for max- 
imal basal transcription and its function appears to be strictly 
position-dependent because constructs with this fragment posi- 
tioned upstream of the start site are not active (Fig. 2). The 
possibility must be considered that the deletion + 10/+ 50 inter- 
rupted a functional element, and the apparent position depend- 
ence in fact reflects only that the whole element was not trans- 
planted. However, the band shifts observed with fragment C 
argue that some complete element is indeed present in this 
region. The + 1/+ 30 region is perfectly conserved among differ- 
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ent species, while the adjacent sequences are only partially 
conserved. This also points to the possible crucial role of this 
region in the regulation of galectin-I gene expression. 
4.2. Activity of galectin-1 promoter in different cell lines 
The modulation of galectin-1 expression during develop- 
ment, the striking increase of galectin-1 mRNA levels in trans- 
formed cells and in tumors and the observation that this regu- 
lation occurs at the transcriptional level [14,15], prompted us 
to study the activity of the promoter constructs in differentiated 
and in transformed cell lines. The cell lines used in this study 
showed differences in endogenous galectin-1 mRNA levels of 
up to 100-fold. The data described here indicate that in tran- 
sient transfections, the expression of various galectin-l-pro- 
moter/CAT vectors, containing at least the minimal promoter 
and up to 2300 bp of the upstream region, was comparable in 
strength among the different cell lines. These results indicate 
that the differential expression of the endogenous galectin-1 
gene cannot be reproduced by transient ransfection of the 
constructs used in this study. 
We previously demonstrated that cell hybrids resulting from 
the fusion of human osteosarcoma (expressing galectin-1 gene) 
with rat FAO cells (non-expressing) show activation of the 
FAO galectin-1 alleles [18]. These data suggested that the donor 
cells contain regulatory factors that activate FAO galectin-1 
alleles. Now we show that promoter constructs are transacti- 
vated by factors present in both expressing and non-expressing 
cells. Thus, we can hypothesize the existence of a repressor that 
acts in trans on a genomic region not contained in our con- 
structs, and a mechanism of derepression that activates the gene 
in expressing-cells and in hybrids. Alternatively, the gene could 
be repressed in non-producing cells through a mechanism in 
'cis', non-functional on transiently transfected promoters, and 
derepressed in the hybrids in a dominant fashion. In this respect 
it is noteworthy that the treatment of FAO cells with 5'-aza- 
cytidine, a DNA demethylating a ent, leads to activation of the 
galectin-1 gene [18]; these observations uggest that DNA 
methylation is involved in the regulation of galectin-1 gene 
expression in different cell lines. 
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